[HTML][HTML] Emerging degrader technologies engaging lysosomal pathways
Targeted protein degradation (TPD) provides unprecedented opportunities for drug
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
[HTML][HTML] Emerging degrader technologies engaging lysosomal pathways
Y Ding, D Xing, Y Fei, B Lu - Chemical Society Reviews, 2022 - ncbi.nlm.nih.gov
Targeted protein degradation (TPD) provides unprecedented opportunities for drug
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
Emerging degrader technologies engaging lysosomal pathways.
Y Ding, D Xing, Y Fei, B Lu - Chemical Society Reviews, 2022 - europepmc.org
Targeted protein degradation (TPD) provides unprecedented opportunities for drug
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
Emerging degrader technologies engaging lysosomal pathways
Y Ding, D Xing, Y Fei, B Lu - Chemical Society reviews, 2022 - pubmed.ncbi.nlm.nih.gov
Targeted protein degradation (TPD) provides unprecedented opportunities for drug
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …